CJC-1295 research guide for Perthes. Covers DAC vs no-DAC forms, half-life differences, purity testing, and how to source quality CJC-1295 for research.
CJC-1295 won't be found on pharmacy shelves in Perthes or virtually any local market — this is a specialist compound available through a dedicated online market. The practical advantage of this online-only market is that serious vendors are judged entirely by their analytical documentation, giving researchers better verification tools than local retail ever could. The core quality markers for CJC-1295 are HPLC purity ≥98%, molecular identity confirmed by mass spectrometry, and a bacterial endotoxin panel — all documented in a batch-specific Certificate of Analysis. This guide gives Perthes researchers the practical tools to evaluate CJC-1295 vendors systematically and source research-grade CJC-1295 with confidence.
What Studies Say About CJC-1295
CJC-1295 with DAC (Drug Affinity Complex) is a GHRH analogue with an extended half-life achieved through DAC technology that enables covalent binding to albumin. This modification extends the half-life from minutes (for native GHRH) to approximately 6-8 days, creating a sustained elevation in basal GH levels rather than the pulsatile pattern produced by GHRP compounds. This pharmacokinetic distinction is significant for research design: CJC-1295 based on CJC-1295 with DAC produces a different GH secretion pattern than GHRP compounds, with different downstream effects on IGF-1 and protein synthesis. Researchers in Perthes comparing compounds in this class should account for these pharmacokinetic differences in their experimental design.
How to Source CJC-1295 — Vendor Guide
The first step for any Perthes researcher sourcing CJC-1295 is finding vendors with verified community track records — search results alone are too heavily influenced by marketing spend. The HPLC chromatogram is the most important document in the COA: it should show a dominant main peak representing CJC-1295, with small or absent impurity peaks representing impurities — purity should be 98% or higher. Community reputation in research forums is a valuable complement to COA verification — vendors with consistently positive reports over 12+ months have built their reputation on real product performance. The lyophilised (freeze-dried) form of CJC-1295 is much more stable than liquid pre-made solutions — lyophilised powder stays viable for years at −20°C, while liquid preparations lose activity within weeks.
Order CJC-1295 — ships to Perthes
COA-verified · International tracking · Research grade
Research compound status for CJC-1295 means safety data comes from animal studies, in-vitro work, and limited human observations — rather than the controlled trials that generate pharmaceutical safety profiles. Proper handling of CJC-1295 requires strict sterile technique during reconstitution — prep pad-cleaned septum, single-use needles, uncontaminated workspace — and consistent cold chain handling. Bacterial endotoxin contamination is the primary safety concern associated with research-grade peptides — verify endotoxin testing is included in the batch-specific COA before any injectable research application. For any individual considering CJC-1295 outside a formal research context: seek medical advice first — this compound is not a licensed human medication and its risk profile is not equivalent to approved medications.
Frequently Asked Questions
What is the difference between CJC-1295 with DAC and without DAC?
CJC-1295 with DAC uses a lysine-maleimide conjugate to bind covalently to albumin in the bloodstream, extending half-life to ~6-8 days and creating sustained GH elevation. CJC-1295 without DAC (also called Mod GRF 1-29) has a half-life of ~30 minutes and produces acute GH pulses. They produce different GH secretion patterns and have different applications in research.
What purity is required for CJC-1295 research?
CJC-1295 should be ≥98% pure by HPLC. The larger molecular weight of CJC-1295 with DAC (approximately 3647 Da) makes mass spectrometry confirmation particularly important, as impurities may not be obvious on HPLC alone.
What is CJC-1295?
CJC-1295 is a synthetic GHRH (Growth Hormone Releasing Hormone) analogue. The version with DAC (Drug Affinity Complex) has an extended half-life of approximately 6-8 days due to albumin binding. Without DAC, CJC-1295 has a much shorter half-life similar to native GHRH. Both versions stimulate pulsatile GH release via the GHRH receptor.
